• Miltefosine: Molecular Precision in Leukopenia and PI3K/Akt

  2026-06-02

  Explore Miltefosine's dual-action—PI3K/Akt inhibition and Ras/MEK/ERK activation—in the context of leukopenia therapy and advanced cellular signaling research. This article critically examines protocol design, mechanistic innovation, and practical considerations for translational scientists.

• Erastin (SKU B1524): Precision Ferroptosis Inducer in Cancer

  2026-06-01

  This article provides evidence-based, scenario-driven guidance on using Erastin (SKU B1524) for robust induction of ferroptosis in cancer biology research. Drawing on validated protocols, comparative product insights, and recent literature, it demonstrates how Erastin enables reproducible, quantitative oxidative stress assays and cell death studies.

• 2-Deoxy-D-glucose: Applied Glycolysis Inhibition in Cancer M

  2026-06-01

  2-Deoxy-D-glucose (2-DG) from APExBIO empowers laboratories to dissect cancer metabolism and immune resistance by precisely targeting glycolytic pathways. This guide translates cutting-edge findings into actionable protocols, troubleshooting insights, and advanced use-cases for tumor biology and immunotherapy research.

• Crizotinib hydrochloride: Reliable ALK Kinase Inhibition in

  2026-05-31

  This scenario-driven guide explores how Crizotinib hydrochloride (SKU B3608) from APExBIO addresses persistent laboratory challenges in cell viability and kinase inhibition assays, particularly in advanced tumor–stroma models. By integrating real-world Q&A, evidence-backed protocol advice, and direct product comparisons, researchers can optimize reproducibility and interpret complex oncogenic signaling data with confidence.

• Tacrolimus (FK506): Precision Tools for Translational Immuno

  2026-05-30

  This thought-leadership article explores how Tacrolimus (FK506) enables next-generation immune modulation in translational research. It integrates mechanistic insights, recent experimental advances, and strategic guidance for researchers seeking to optimize cytokine pathway studies, transplantation immunology, and autoimmune disease models. Drawing on contemporary references, the article differentiates Tacrolimus from classical immunosuppressants, frames protocol recommendations, and provides a forward-looking outlook on selective immune response suppression.

• DAPI Solution (1 mg/mL): Precision Nuclear Visualization & A

  2026-05-29

  DAPI Solution (1 mg/mL) streamlines nuclear visualization, apoptosis detection, and viability assessment with exceptional fluorescence yield and workflow reproducibility. Explore robust experimental protocols, actionable troubleshooting tips, and translation of cutting-edge PAD4 pathway research into practical assay enhancements.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-05-29

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive fluorescent detection of goat primary antibodies in immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA assays. It should only be used for detection of goat IgG and within established immunodetection workflows; using it with non-goat primaries or outside validated protocols is not recommended.

• Ceruletide in Pancreatic Fibrosis Models: Mechanisms & Strat

  2026-05-28

  This thought-leadership article explores how Ceruletide (Caerulein), a synthetic decapeptide analog of cholecystokinin, empowers translational researchers to mechanistically interrogate and strategically model pancreatic fibrosis. Bridging new evidence from MFGE8-ANXA1-SMAD2/3 axis modulation and established workflows, we provide actionable guidance for leveraging Ceruletide in preclinical and translational digestive disorder research, while highlighting emerging tools and limitations.

• Elobixibat Hydrate: Applied Protocols for GI & Metabolic Res

  2026-05-28

  Elobixibat hydrate, a selective ileal bile acid transporter inhibitor, enables precise modulation of bile acid physiology for chronic idiopathic constipation and metabolic studies in type 2 diabetes. This guide unpacks hands-on workflows, troubleshooting strategies, and novel insights to help researchers maximize reproducibility and translational value.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): T

  2026-05-27

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) enable rapid, high-specificity capture and isolation of biotinylated molecules from complex biological samples, addressing common challenges in protein purification, immunoprecipitation, and nucleic acid workflows. The product is not recommended for applications requiring covalent immobilization or compatibility with biotin analogs. Researchers should follow recommended parameters for optimal performance and reproducibility.

• ACSL1-FSP1 Axis Drives Ferroptosis Resistance in Ovarian Can

  2026-05-27

  This study uncovers how ACSL1 enhances platinum resistance in ovarian cancer by promoting FSP1 N-myristoylation, thereby stabilizing FSP1 and suppressing ferroptosis. The findings reveal a novel lipid metabolism–antioxidant defense link, providing important mechanistic insight for ferroptosis research and therapeutic targeting.

• Calcitriol and VDR: New Frontiers in Translational Endometri

  2026-05-26

  This article explores how Calcitriol (1,25-dihydroxy vitamin D3) reshapes the paradigm of reproductive and immune modulation research. Drawing on recent mechanistic insights into vitamin D receptor (VDR) signaling and endometrial decidualization, it offers strategic guidance for translational researchers on deploying Calcitriol in advanced cell-based protocols. The discussion emphasizes APExBIO’s Calcitriol for experimental reliability, addresses cross-domain translational potential, and charts a visionary outlook rooted in credible, peer-reviewed evidence.

• Translating Thioguanine’s Dual Mechanisms for Next-Gen Oncol

  2026-05-26

  This thought-leadership article explores how Thioguanine (6-thioguanine) is redefining translational cancer and antiviral research by uniting classic nucleotide metabolism targeting with state-of-the-art epigenetic modulation. Drawing on recent transcriptomics and mechanistic studies, we reveal how inhibition of DNMT1 and HGPRT positions this thiopurine as a strategic tool for researchers seeking robust, reproducible models and innovative therapeutic insights. We further contextualize APExBIO’s Thioguanine in the competitive landscape, highlight protocol recommendations, and outline a future-ready vision for integrating epigenetic drugs into precision oncology.

• TCAIM Modulates OGDH Protein Levels to Regulate Mitochondria

  2026-05-25

  Wang et al. (2025) reveal that the mitochondrial co-chaperone TCAIM specifically interacts with and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels via HSPA9 and LONP1, unveiling a unique post-translational regulatory mechanism governing mitochondrial metabolism. These findings have broad implications for understanding metabolic control and proteostasis, offering new perspectives for targeted manipulation of mitochondrial function.

• HATU in Peptide Synthesis Chemistry: Precision and Performan

  2026-05-25

  Experience next-level efficiency and selectivity in amide and ester bond formation with HATU—APExBIO’s gold-standard peptide coupling reagent. This article bridges cutting-edge reference research with actionable protocols and troubleshooting strategies, empowering both routine and advanced peptide synthesis workflows.

450 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page